Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation.

PubWeight™: 2.52‹?› | Rank: Top 2%

🔗 View Article (PMID 7736574)

Published in Cell on April 21, 1995

Authors

T Miyazaki1, Z J Liu, A Kawahara, Y Minami, K Yamada, Y Tsujimoto, E L Barsoumian, R M Permutter, T Taniguchi

Author Affiliations

1: Institute for Molecular and Cellular Biology, Osaka University, Japan.

Articles citing this

Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity (2008) 6.08

Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc Natl Acad Sci U S A (1997) 3.83

The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity. EMBO J (2006) 3.57

Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway. EMBO J (1997) 3.34

Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. Proc Natl Acad Sci U S A (1996) 2.19

Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. Mol Cell Biol (1996) 2.17

Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation. EMBO J (1996) 2.07

Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death. J Exp Med (1996) 1.98

Interleukin-2 receptor signaling in regulatory T cell development and homeostasis. Immunol Lett (2007) 1.91

Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proc Natl Acad Sci U S A (1996) 1.75

Signals through gp130 upregulate bcl-x gene expression via STAT1-binding cis-element in cardiac myocytes. J Clin Invest (1997) 1.65

Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells. EMBO J (1996) 1.65

A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR beta oncoprotein. EMBO J (1997) 1.60

Bax alpha perturbs T cell development and affects cell cycle entry of T cells. EMBO J (1996) 1.43

PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells. J Clin Invest (2013) 1.42

Human T-cell leukemia virus type 1 Tax protein transforms rat fibroblasts via two distinct pathways. J Virol (1997) 1.40

c-Myc mediates pre-TCR-induced proliferation but not developmental progression. Blood (2006) 1.39

A novel pathway from phosphorylation of tyrosine residues 239/240 of Shc, contributing to suppress apoptosis by IL-3. EMBO J (1996) 1.39

The Gfi-1 protooncoprotein represses Bax expression and inhibits T-cell death. Proc Natl Acad Sci U S A (1996) 1.38

Modulation of T-lymphocyte development, growth and cell size by the Myc antagonist and transcriptional repressor Mad1. EMBO J (2002) 1.36

Interleukin 2: from immunostimulation to immunoregulation and back again. EMBO Rep (2007) 1.31

Interleukin-7 or interleukin-15 enhances survival of Mycobacterium tuberculosis-infected mice. Infect Immun (2000) 1.29

Mechanisms of T-cell activation by human T-cell lymphotropic virus type I. Microbiol Mol Biol Rev (1999) 1.27

Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice. Rheumatology (Oxford) (2009) 1.26

Aiolos transcription factor controls cell death in T cells by regulating Bcl-2 expression and its cellular localization. EMBO J (1999) 1.26

Fc gamma R-dependent mitogen-activated protein kinase activation in leukocytes: a common signal transduction event necessary for expression of TNF-alpha and early activation genes. J Exp Med (1996) 1.25

BCL2 regulates neural differentiation. Proc Natl Acad Sci U S A (1996) 1.22

Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action. Clin Microbiol Rev (1999) 1.21

Interleukin-2-independent proliferation of human melanoma-reactive T lymphocytes transduced with an exogenous IL-2 gene is stimulation dependent. J Immunother (2003) 1.16

Stat proteins control lymphocyte proliferation by regulating p27Kip1 expression. Mol Cell Biol (1998) 1.15

Low-grade B cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signaling and Th2-type cytokines for in vitro growth and differentiation. Am J Pathol (1997) 1.15

IL-15: a central regulator of celiac disease immunopathology. Immunol Rev (2014) 1.14

Human T-cell leukemia virus type 1 tax protein abrogates interleukin-2 dependence in a mouse T-cell line. J Virol (1999) 1.12

The protooncogene MYC can break B cell tolerance. Proc Natl Acad Sci U S A (2005) 1.10

Mixed-lineage kinase 3 delivers CD3/CD28-derived signals into the IkappaB kinase complex. Mol Cell Biol (2000) 1.10

IL-2R signaling is essential for functional maturation of regulatory T cells during thymic development. J Immunol (2013) 1.07

Critical role of the interleukin 2 (IL-2) receptor gamma-chain-associated Jak3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene induction. Proc Natl Acad Sci U S A (1995) 1.07

A membrane-proximal region of the interleukin-2 receptor gamma c chain sufficient for Jak kinase activation and induction of proliferation in T cells. Mol Cell Biol (1996) 1.04

Expression of Bcl-2 family during liver regeneration and identification of Bcl-x as a delayed early response gene. Am J Pathol (1997) 1.03

Involvement of p59fynT in interleukin-5 receptor signaling. J Exp Med (1995) 1.03

Neisseria gonorrhoeae enhances HIV-1 infection of primary resting CD4+ T cells through TLR2 activation. J Immunol (2010) 1.01

Tyrosine-599 of the c-Mpl receptor is required for Shc phosphorylation and the induction of cellular differentiation. EMBO J (1996) 1.00

Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1, and Bax in tumors of central and peripheral nervous system origin. Am J Pathol (1997) 1.00

Hierarchy of protein tyrosine kinases in interleukin-2 (IL-2) signaling: activation of syk depends on Jak3; however, neither Syk nor Lck is required for IL-2-mediated STAT activation. Mol Cell Biol (2000) 0.99

Influence of interleukin polymorphisms on development of gastric cancer and peptic ulcer. World J Gastroenterol (2010) 0.97

Concomitant analysis of Helios and Neuropilin-1 as a marker to detect thymic derived regulatory T cells in naïve mice. Sci Rep (2015) 0.96

A critical role for cyclin C in promotion of the hematopoietic cell cycle by cooperation with c-Myc. Mol Cell Biol (1998) 0.96

Carcinoembryonic antigen, a human tumor marker, cooperates with Myc and Bcl-2 in cellular transformation. J Cell Biol (1997) 0.96

Gamma(c) deficiency precludes CD8+ T cell memory despite formation of potent T cell effectors. Proc Natl Acad Sci U S A (2010) 0.95

Functions of IL-15 in anti-viral immunity: multiplicity and variety. Cytokine (2012) 0.94

Expression of the c-myc proto-oncogene is essential for HIV-1 infection in activated T cells. J Exp Med (1999) 0.92

Recent advances in the understanding of interleukin-2 signal transduction. J Clin Immunol (1998) 0.91

Redundant promoter elements mediate IL-3-induced expression of a novel cytokine-inducible gene, cyclon. FEBS Lett (2007) 0.90

Molecular pathways: interleukin-15 signaling in health and in cancer. Clin Cancer Res (2014) 0.90

Ribosomal proteins L5 and L11 co-operatively inactivate c-Myc via RNA-induced silencing complex. Oncogene (2013) 0.89

T cell immunity as a tool for studying epigenetic regulation of cellular differentiation. Front Genet (2013) 0.89

Defining the molecular blueprint that drives CD8(+) T cell differentiation in response to infection. Front Immunol (2012) 0.87

Differential requirements for c-Myc in chronic hematopoietic hyperplasia and acute hematopoietic malignancies in Pten-null mice. Leukemia (2011) 0.85

Preferential control of induced regulatory T cell homeostasis via a Bim/Bcl-2 axis. Cell Death Dis (2012) 0.84

Cleavage of functional IL-2 receptor alpha chain (CD25) from murine corneal and conjunctival epithelia by MMP-9. J Inflamm (Lond) (2009) 0.84

Ligation of CD8 leads to apoptosis of thymocytes that have not undergone positive selection. Proc Natl Acad Sci U S A (2004) 0.83

Distinct patterns of Bcl-2 expression occur in R5- and X4-tropic HIV-1-producing lymphoid tissue cells infected ex vivo. AIDS Res Hum Retroviruses (2014) 0.82

Interactions between Myc and Mediators of Inflammation in Chronic Liver Diseases. Mediators Inflamm (2015) 0.81

Distinct populations of innate CD8+ T cells revealed in a CXCR3 reporter mouse. J Immunol (2013) 0.80

Transgenic Bcl-3 slows T cell proliferation. Int Immunol (2009) 0.79

HIV-1 Infection-Induced Suppression of the Let-7i/IL-2 Axis Contributes to CD4(+) T Cell Death. Sci Rep (2016) 0.79

Temporal regulation of Stat5 activity in determination of cell differentiation program. Biochem Biophys Res Commun (2007) 0.78

Homeostatic proliferation and IL-7R alpha expression do not correlate with enhanced T cell proliferation and protection in chronic mouse malaria. PLoS One (2011) 0.78

Interleukin-2 induces beta2-integrin-dependent signal transduction involving the focal adhesion kinase-related protein B (fakB). Proc Natl Acad Sci U S A (1998) 0.77

Discordant effects of interleukin-2 on viral and immune parameters in human immunodeficiency virus-1-infected monocyte-derived mature dendritic cells. Clin Exp Immunol (2003) 0.77

IL-2 -330T/G polymorphism and cancer risk: a meta-analysis. Onco Targets Ther (2015) 0.76

Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseases. Clin Exp Immunol (2017) 0.75

Expression of bovine interleukin 15 and evaluation of its biological activity in vitro. Vet World (2015) 0.75

Isozymes of nuclear protein tyrosine kinase during chemical induced hepatocarcinogenesis in rats. J Cancer Res Clin Oncol (1997) 0.75

Articles by these authors

The complete nucleotide sequence of the tobacco chloroplast genome: its gene organization and expression. EMBO J (1986) 19.59

Microfilaments in cellular and developmental processes. Science (1971) 13.56

Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity (2000) 10.34

Boron nitride substrates for high-quality graphene electronics. Nat Nanotechnol (2010) 9.72

Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements. Cell (1988) 9.04

Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell (2001) 8.99

Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science (1984) 8.80

Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science (2000) 8.74

Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature (1999) 8.70

Involvement of the bcl-2 gene in human follicular lymphoma. Science (1985) 8.19

Structure and expression of a cloned cDNA for human interleukin-2. Nature (1983) 7.04

Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science (1995) 6.81

The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science (1985) 6.63

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature (2000) 6.49

A new protein containing an SH2 domain that inhibits JAK kinases. Nature (1997) 6.28

Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell (1989) 6.11

Nucleotide sequence heterogeneity of an RNA phage population. Cell (1978) 5.55

Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci U S A (1986) 5.54

Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature (1985) 5.32

Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science (1997) 5.13

Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's. Science (1989) 5.08

Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. Science (1988) 4.93

Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1. EMBO J (1986) 4.58

Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1-encoded p40x and T3/Ti complex triggering. Cell (1987) 4.10

Hip, a novel cochaperone involved in the eukaryotic Hsc70/Hsp40 reaction cycle. Cell (1995) 3.99

Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res (1997) 3.98

Regulation of human interleukin-2 gene: functional DNA sequences in the 5' flanking region for the gene expression in activated T lymphocytes. Cell (1986) 3.88

Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association. Science (1991) 3.84

Interaction site of Escherichia coli cyclic AMP receptor protein on DNA of galactose operon promoters. Proc Natl Acad Sci U S A (1979) 3.83

Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett (1998) 3.80

The nucleotide sequence of human fibroblast interferon cDNA. Gene (1980) 3.80

Massive Dirac fermions and Hofstadter butterfly in a van der Waals heterostructure. Science (2013) 3.79

Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis (2008) 3.77

A restricted cytoplasmic region of IL-2 receptor beta chain is essential for growth signal transduction but not for ligand binding and internalization. Cell (1989) 3.70

Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science (1984) 3.64

The DNA sequence of Bombyx mori fibroin gene including the 5' flanking, mRNA coding, entire intervening and fibroin protein coding regions. Cell (1979) 3.60

Absence of the type I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated. Cell (1990) 3.58

Delimitation and properties of DNA sequences required for the regulated expression of human interferon-beta gene. Cell (1985) 3.57

Human leukocyte and fibroblast interferons are structurally related. Nature (1980) 3.57

Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell (1994) 3.56

Interferon-beta gene regulation: tandemly repeated sequences of a synthetic 6 bp oligomer function as a virus-inducible enhancer. Cell (1987) 3.51

K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem Biophys Res Commun (1987) 3.46

Structure of the human interleukin 2 gene. Proc Natl Acad Sci U S A (1983) 3.45

Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ (2009) 3.44

Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation. Nature (1999) 3.43

Clinical features of isolated noncompaction of the ventricular myocardium: long-term clinical course, hemodynamic properties, and genetic background. J Am Coll Cardiol (1999) 3.38

Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc Natl Acad Sci U S A (1998) 3.35

The IL-2/IL-2 receptor system: a current overview. Cell (1993) 3.33

Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1. Nature (1989) 3.25

CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein. EMBO Rep (2001) 3.19

Expression of the pX gene of HTLV-I: general splicing mechanism in the HTLV family. Science (1985) 3.18

Structural analysis of the fibroin gene at the 5' end and its surrounding regions. Cell (1979) 3.16

QB DNA-containing hybrid plasmids giving rise to QB phage formation in the bacterial host. Nature (1978) 3.11

Evidence for a nuclear factor(s), IRF-1, mediating induction and silencing properties to human IFN-beta gene regulatory elements. EMBO J (1988) 3.11

THE CAUSE OF RAT-BITE FEVER. J Exp Med (1916) 3.10

Comparison of diameter and perimeter methods for tumor volume calculation. J Clin Oncol (2001) 3.09

The IL-2 receptor complex: its structure, function, and target genes. Annu Rev Immunol (1993) 2.96

Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Nature (1985) 2.91

One-dimensional electrical contact to a two-dimensional material. Science (2013) 2.87

Wortmannin, a microbial product inhibitor of myosin light chain kinase. J Biol Chem (1992) 2.85

An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature (1995) 2.79

Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-beta gene. FEBS Lett (1998) 2.76

Characterization of mSelB, a novel mammalian elongation factor for selenoprotein translation. EMBO J (2000) 2.72

Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains. Science (2000) 2.67

Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science (1994) 2.65

Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science (1993) 2.63

Structure and expression of a cloned cDNA for mouse interferon-beta. J Biol Chem (1983) 2.61

Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science (1992) 2.60

Building a multichain receptor: synthesis, degradation, and assembly of the T-cell antigen receptor. Proc Natl Acad Sci U S A (1987) 2.58

Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol Cell Biol (1993) 2.51

Structure of a chromosomal gene for human interferon beta. Proc Natl Acad Sci U S A (1981) 2.50

Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol (1993) 2.50

T cell activation induces rapid tyrosine phosphorylation of a limited number of cellular substrates. J Biol Chem (1989) 2.50

Scanning tunnelling microscopy and spectroscopy of ultra-flat graphene on hexagonal boron nitride. Nat Mater (2011) 2.48

ACCOMMODATION AND OTHER OPTICAL PROPERTIES OF THE EYE OF THE CAT. Br J Ophthalmol (1922) 2.48

Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature (1995) 2.40

Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways. Proc Natl Acad Sci U S A (1989) 2.38

Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation. Science (1987) 2.36

Unusual location and function of the operator in the Escherichia coli galactose operon. Nature (1979) 2.35

Critical role of a common transcription factor, IRF-1, in the regulation of IFN-beta and IFN-inducible genes. EMBO J (1992) 2.34

Amelioration of hippocampal neuronal damage after global ischemia by neuronal overexpression of BCL-2 in transgenic mice. Stroke (1998) 2.34

Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol Cell (2001) 2.33

Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE). Nucleic Acids Res (1995) 2.33

Activation of IFN-beta element by IRF-1 requires a posttranslational event in addition to IRF-1 synthesis. Nucleic Acids Res (1991) 2.33

Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI. J Neurol Neurosurg Psychiatry (2004) 2.32

Vascular imprints of neuronal activity: relationships between the dynamics of cortical blood flow, oxygenation, and volume changes following sensory stimulation. Proc Natl Acad Sci U S A (1997) 2.28

Syk activation by the Src-family tyrosine kinase in the B cell receptor signaling. J Exp Med (1994) 2.26

The L- and R-type isozymes of rat pyruvate kinase are produced from a single gene by use of different promoters. J Biol Chem (1987) 2.25

IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc. Cell (1992) 2.25

A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes. Mol Cell Biol (1996) 2.18

Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature (1998) 2.17

KT5926, a potent and selective inhibitor of myosin light chain kinase. Mol Pharmacol (1990) 2.16

Unique structure of murine interleukin-2 as deduced from cloned cDNAs. Nature (1985) 2.15

Reconstitution of functional receptor for human interleukin-2 in mouse cells. Nature (1986) 2.14

Hofstadter's butterfly and the fractal quantum Hall effect in moiré superlattices. Nature (2013) 2.13